lacosamide
lacosamide is listed in the FDA National Drug Code directory with 44 NDC codes, marketed under brand names including Lacosamide, lacosamide, Vimpat. Available dosage forms: injection, tablet, film coated, powder, capsule, extended release, solution.
Drug details
- Generic Name
- lacosamide
- Brand Names
- Lacosamide, lacosamide, Vimpat, MOTPOLY XR
- Application Number
- ANDA216670
- Sponsor
- Apotex Corp
- NDC Codes
- 44
- Dosage Forms
- INJECTION, TABLET, FILM COATED, POWDER, CAPSULE, EXTENDED RELEASE, SOLUTION, INJECTION, SOLUTION
- Routes
- INTRAVENOUS, ORAL
- Active Ingredients
- LACOSAMIDE
Indications and Usage
1 INDICATIONS AND USAGE Lacosamide oral solution is indicated for: Treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide oral solution is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.